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journal homepage: http: / /www.elsevier .com/locate/rethLetter to the editorRegenerative medicine for esophageal reconstruction after cancer
treatmentWe read with interest a review of the esophageal reconstruction
reported by Kerm and colleagues [1], and would like to add some
information pertaining to the various therapies covering endosur-
gical defects. The authors pointed out that few patients were
included in the clinical trials and a more extensive clinical study
is needed to establish the efﬁcacy. They further state that full-
thickness tissue replacement after esophagectomy remains a chal-
lenge. Advances in stem cell and cell-sheet technologies could pro-
vide the ultimate solution to complications after esophagectomy,
e.g. postsurgical strictures and stenoses. We agree. As mentioned
in their ﬁne review, we published a pilot study in ten patients
with autologous oral mucosal cells cultivated on membranes (cell
sheet) [1]. In the meantime, we have performed additional pro-
spective clinical studies in Sweden as well as in Japanwhere 30 pa-
tients after ESD or RFA (Barrett's esophagus) were treated [2]. The
favorable outcomes of these studies will be published soon (manu-
scripts in preparation) and a randomized clinical trial is planned.
These clinical studies, by virtue of in vitro experiments demon-
strating the activation of stem cells and using confocal laser micro-
scopy to monitor the healing of these cell sheets, underscore the
feasibility and rationale of such an approach [3].
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